{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:07:48Z","timestamp":1761487668517,"version":"build-2065373602"},"reference-count":117,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.tmaid.2006.03.002","type":"journal-article","created":{"date-parts":[[2006,5,20]],"date-time":"2006-05-20T07:22:44Z","timestamp":1148109764000},"page":"7-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Travel medicine interventions and neurological disease"],"prefix":"10.1016","volume":"5","author":[{"given":"Franco","family":"Giovanetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2006.03.002_bib1","unstructured":"World Tourism Organization. Tourism highlights. Madrid: WTO; 2005. Available at: http:\/\/www.world-tourism.org"},{"issue":"6","key":"10.1016\/j.tmaid.2006.03.002_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archinte.158.6.633","article-title":"Typhoid fever in the United States, 1985\u20131994: changing risks of international travel and increasing antimicrobial resistance","volume":"158","author":"Mermin","year":"1998","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.tmaid.2006.03.002_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2310\/7060.2005.00006","article-title":"Vaccines in travel health: from risk assessment to priorities","volume":"12","author":"Steffen","year":"2005","journal-title":"J Travel Med"},{"issue":"9396","key":"10.1016\/j.tmaid.2006.03.002_bib4","first-page":"1659","volume":"362","author":"Wraith","year":"2003","journal-title":"Vaccination and autoimmune disease: what is the evidence? Lancet"},{"issue":"1","key":"10.1016\/j.tmaid.2006.03.002_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08916930500484799","article-title":"Multiple sclerosis and virus induced immune responses: autoimmunity can be primed by molecular mimicry and augmented by bystander activation","volume":"39","author":"McCoy","year":"2006","journal-title":"Autoimmunity"},{"issue":"3","key":"10.1016\/j.tmaid.2006.03.002_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/088282401753266756","article-title":"Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease","volume":"14","author":"Olson","year":"2001","journal-title":"Viral Immunol"},{"key":"10.1016\/j.tmaid.2006.03.002_bib7","unstructured":"Institute of Medicine. Immunization safety review: hepatitis B vaccine and demyelinating neurological disorders. Washington, DC: National Academy Press; 2002."},{"issue":"2","key":"10.1016\/j.tmaid.2006.03.002_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/clinids\/12.2.204","article-title":"Virus-induced autoimmunity","volume":"12","author":"Schattner","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2006.03.002_bib9","first-page":"653","volume":"111","author":"Offit","year":"2003","journal-title":"Addressing parents\u2019 concerns: do vaccines cause allergic or autoimmune diseases? Pediatrics"},{"issue":"2","key":"10.1016\/j.tmaid.2006.03.002_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1473-3099(04)00927-2","article-title":"Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence","volume":"4","author":"Jefferson","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.tmaid.2006.03.002_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0896-8411(03)00083-0","article-title":"Induction of lupus autoantibodies by adjuvants","volume":"21","author":"Satoh","year":"2003","journal-title":"J Autoimmun"},{"issue":"27\u201330","key":"10.1016\/j.tmaid.2006.03.002_bib12","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1016\/S0264-410X(03)00456-0","article-title":"Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults","volume":"21","author":"Frey","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.03.002_bib13","first-page":"85","article-title":"Causality assessment of adverse events following immunization","volume":"76","year":"2001","journal-title":"Wkly Epidemiol Record"},{"issue":"RR-2","key":"10.1016\/j.tmaid.2006.03.002_bib14","first-page":"1","article-title":"General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)","volume":"51","author":"Atkinson","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.tmaid.2006.03.002_bib15","unstructured":"Arguin PM, Kozarsky PE, Navin AW. Yellow book: health information for international travel, 2005\u20132006. US Department of Health and Human Services: 2005. Available at: http:\/\/www.cdc.gov\/travel\/yb"},{"issue":"12","key":"10.1016\/j.tmaid.2006.03.002_bib16","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1212\/01.wnl.0000188901.12700.e0","article-title":"Rebif-Influenza Vaccine Study Investigators: immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1a","volume":"65","author":"Schwid","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.tmaid.2006.03.002_bib17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0264-410X(94)90116-3","article-title":"Randomized comparative trial of interferon-alpha versus placebo in hepatitis B vaccine non-responders and hyporesponders","volume":"12","author":"Goldwater","year":"1994","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.tmaid.2006.03.002_bib18","first-page":"CR379","article-title":"Hepatitis B vaccine immunogenicity in patients with chronic HCV infection at one year follow-up: the effect of interferon-alpha therapy","volume":"8","author":"Chlabicz","year":"2002","journal-title":"Med Sci Monit"},{"issue":"Part 5","key":"10.1016\/j.tmaid.2006.03.002_bib19","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/brain\/awf098","article-title":"Prospective study on the relationship between infections and multiple sclerosis exacerbations","volume":"125","author":"Buljevac","year":"2002","journal-title":"Brain"},{"issue":"9497","key":"10.1016\/j.tmaid.2006.03.002_bib20","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.tmaid.2006.03.002_bib21","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","article-title":"Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation","volume":"48","author":"Thomas","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.tmaid.2006.03.002_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s100720170014","article-title":"Vaccinations and multiple sclerosis","volume":"22","author":"Gout","year":"2001","journal-title":"Neurol Sci"},{"issue":"4","key":"10.1016\/j.tmaid.2006.03.002_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jon199664248","article-title":"Acute transverse myelitis after influenza vaccination: magnetic resonance imaging findings","volume":"6","author":"Bakshi","year":"1996","journal-title":"J Neuroimag"},{"issue":"5","key":"10.1016\/j.tmaid.2006.03.002_bib24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0002-9394(14)70918-3","article-title":"Optic neuritis after influenza vaccination","volume":"124","author":"Hull","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.tmaid.2006.03.002_bib25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00041327-199609000-00004","article-title":"Bilateral optic neuropathy associated with influenza vaccination","volume":"16","author":"Ray","year":"1996","journal-title":"J Neuroophthalmol"},{"issue":"6043","key":"10.1016\/j.tmaid.2006.03.002_bib26","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bmj.2.6043.1037","article-title":"Diffuse myelitis associated with rubella vaccination","volume":"2","author":"Holt","year":"1976","journal-title":"Br Med J"},{"issue":"9\u201310","key":"10.1016\/j.tmaid.2006.03.002_bib27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1440-1754.2004.00470.x","article-title":"Transverse myelitis after measles and rubella vaccination","volume":"40","author":"Lim","year":"2004","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"10.1016\/j.tmaid.2006.03.002_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0387-7604(02)00020-7","article-title":"Acute transverse myelitis after Japanese B encephalitis vaccination in a 4-year-old girl","volume":"24","author":"Matsui","year":"2002","journal-title":"Brain Dev"},{"issue":"1","key":"10.1016\/j.tmaid.2006.03.002_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0161-6420(01)00844-2","article-title":"Optic neuritis after anthrax vaccination","volume":"109","author":"Kerrison","year":"2002","journal-title":"Ophthalmology"},{"issue":"13","key":"10.1016\/j.tmaid.2006.03.002_bib30","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2006.03.002_bib31","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/bmj.325.7373.1128","article-title":"Infection as a cause of multiple sclerosis","volume":"325","author":"Murray","year":"2002","journal-title":"Br Med J"},{"issue":"15","key":"10.1016\/j.tmaid.2006.03.002_bib32","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1001\/jama.291.15.1875","article-title":"Epstein\u2013Barr virus in pediatric multiple sclerosis","volume":"291","author":"Alotaibi","year":"2004","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.tmaid.2006.03.002_bib33","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/archneur.61.10.1613","article-title":"Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease","volume":"61","author":"Weiner","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.tmaid.2006.03.002_bib34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(85)92801-6","article-title":"Clinical viral infections and multiple sclerosis","volume":"1","author":"Sibley","year":"1985","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.tmaid.2006.03.002_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","article-title":"Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease","volume":"19","author":"Fujinami","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"927","key":"10.1016\/j.tmaid.2006.03.002_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/pmj.79.927.11","article-title":"Acute disseminated encephalomyelitis","volume":"79","author":"Garg","year":"2003","journal-title":"Postgrad Med J"},{"issue":"Part 12","key":"10.1016\/j.tmaid.2006.03.002_bib37","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/brain\/123.12.2407","article-title":"Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children","volume":"123","author":"Dale","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.tmaid.2006.03.002_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s004310050695","article-title":"Acute disseminated demyelination due to primary human herpesvirus-6 infection","volume":"156","author":"Kamei","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.tmaid.2006.03.002_bib39","first-page":"258","article-title":"MRI of acute disseminated encephalomyelitis after coxsackie B infection","volume":"20","author":"David","year":"1993","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.tmaid.2006.03.002_bib40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/archneur.1997.00550170115023","article-title":"Fulminating encephalopathy with perivenular demyelination and vacuolar myelopathy as the initial presentation of human immunodeficiency virus infection","volume":"54","author":"Silver","year":"1997","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.tmaid.2006.03.002_bib41","first-page":"444","article-title":"Postinfectious encephalopathy in a child following Campylobacter jejuni enteritis","volume":"14","author":"Nasralla","year":"1993","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.tmaid.2006.03.002_bib42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/bmj.1.5956.494","article-title":"Acute disseminated encephalomyelitis in typhoid fever","volume":"1","author":"Ramachandran","year":"1975","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.tmaid.2006.03.002_bib43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1212\/WNL.53.2.396","article-title":"Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS?","volume":"53","author":"Tourbah","year":"1999","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.tmaid.2006.03.002_bib44","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/WNL.56.10.1308","article-title":"Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children","volume":"56","author":"Hynson","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.tmaid.2006.03.002_bib45","first-page":"205","article-title":"Sclerotic plaques and vaccination against hepatitis B","volume":"154","author":"Gout","year":"1998","journal-title":"Rev Neurol"},{"issue":"3","key":"10.1016\/j.tmaid.2006.03.002_bib46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/clin.1997.4477","article-title":"Immunoglobulin- and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis B virus infection","volume":"86","author":"Tsai","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"issue":"2","key":"10.1016\/j.tmaid.2006.03.002_bib47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cld.2004.02.003","article-title":"Extrahepatic manifestations of chronic hepatitis B","volume":"8","author":"Han","year":"2004","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.tmaid.2006.03.002_bib48","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.mehy.2005.02.044","article-title":"Multiple sclerosis and hepatitis B vaccination: could minute contamination of the vaccine by partial hepatitis B virus polymerase play a role through molecular mimicry?","volume":"65","author":"Faure","year":"2005","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.tmaid.2006.03.002_bib49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2004.11.007","article-title":"Hepatitis B vaccination and central nervous system demyelination: an immunological approach","volume":"24","author":"Piaggio","year":"2005","journal-title":"J Autoimmun"},{"issue":"1 Part 1","key":"10.1016\/j.tmaid.2006.03.002_bib50","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1542\/peds.110.1.e4","article-title":"No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine","volume":"110","author":"Belloni","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.tmaid.2006.03.002_bib51","unstructured":"Institute of Medicine, Stratton KR, Alamario DA, Wizemann T, McCormick M, editors. Immunization safety review: influenza vaccines and neurological complications. Washington, DC: National Academy Press; 2004."},{"issue":"5","key":"10.1016\/j.tmaid.2006.03.002_bib52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200102013440502","article-title":"Hepatitis B vaccination and the risk of multiple sclerosis","volume":"344","author":"Ascherio","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.tmaid.2006.03.002_bib53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archneur.60.4.504","article-title":"Vaccinations and risk of central nervous system demyelinating diseases in adults","volume":"60","author":"DeStefano","year":"2003","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.tmaid.2006.03.002_bib54","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM200102013440501","article-title":"Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis","volume":"344","author":"Confavreux","year":"2001","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.tmaid.2006.03.002_bib55","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2893.2003.00423.x","article-title":"Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review","volume":"10","author":"Demicheli","year":"2003","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.tmaid.2006.03.002_bib56","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/WNL.48.2.312","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis","volume":"48","author":"Miller","year":"1997","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.tmaid.2006.03.002_bib57","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1212\/WNL.56.7.938","article-title":"Influenza vaccination in MS: absence of T-cell response against white matter proteins","volume":"56","author":"Moriabadi","year":"2001","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.tmaid.2006.03.002_bib58","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.59.12.1837","article-title":"Immunization Panel of the Multiple Sclerosis Council for Clinical Practice Guidelines. Immunization and MS: a summary of published evidence and recommendations","volume":"59","author":"Rutschmann","year":"2002","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.tmaid.2006.03.002_bib59","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1212\/01.WNL.0000138433.61870.82","article-title":"Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study","volume":"63","author":"Hernan","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tmaid.2006.03.002_bib60","unstructured":"World Health Organization Global Advisory Committee on Vaccine Safety. In: Response to the paper by MA Hern\u00e1n and others in Neurology 14th September 2004 issue entitled \u201cRecombinant Hepatitis B Vaccine and the Risk of Multiple Sclerosis\u201d September 2004. Available at : http:\/\/www.who.int\/vaccine_safety\/topics\/hepatitisb\/multiple_sclerosis\/sep_04\/en"},{"key":"10.1016\/j.tmaid.2006.03.002_bib61","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/clinids\/18.4.610","article-title":"Infectious complications of tattoos","volume":"18","author":"Long","year":"1994","journal-title":"CID"},{"issue":"5","key":"10.1016\/j.tmaid.2006.03.002_bib62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2310\/7060.2001.24033","article-title":"Blood and body fluid exposure as a health risk for international travelers","volume":"8","author":"Correia","year":"2001","journal-title":"J Travel Med"},{"issue":"4","key":"10.1016\/j.tmaid.2006.03.002_bib63","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2310\/7060.2000.00054","article-title":"Risks of hepatitis B in travelers as compared to immunization status","volume":"7","author":"Zuckerman","year":"2000","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2006.03.002_bib64","first-page":"789","article-title":"Unsafe injections in the developing world and transmission of bloodborne pathogens: a review","volume":"77","author":"Simonsen","year":"1999","journal-title":"Bull World Health Organ"},{"issue":"Suppl 1","key":"10.1016\/j.tmaid.2006.03.002_bib65","first-page":"S47","article-title":"Vaccine-preventable diseases in long-term expatriates","volume":"12","author":"Dijkstra","year":"2005","journal-title":"J Travel Med"},{"issue":"Suppl 1","key":"10.1016\/j.tmaid.2006.03.002_bib66","first-page":"36","article-title":"Influenza: changing approaches to prevention and treatment in travellers","volume":"12","author":"Freedman","year":"2005","journal-title":"J Travel Med"},{"issue":"2","key":"10.1016\/j.tmaid.2006.03.002_bib67","first-page":"73","article-title":"The use of vaccinations in patients with multiple sclerosis","volume":"19","author":"Jeffery","year":"2002","journal-title":"Infect Med"},{"issue":"9497","key":"10.1016\/j.tmaid.2006.03.002_bib68","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.tmaid.2006.03.002_bib69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0022-510X(87)90235-8","article-title":"P0 myelin protein produces experimental allergic neuritis in Lewis rats","volume":"79","author":"Milner","year":"1987","journal-title":"J Neurol Sci"},{"issue":"Part 10","key":"10.1016\/j.tmaid.2006.03.002_bib70","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/brain\/121.10.1895","article-title":"Induction of experimental autoimmune neuritis with peripheral myelin protein-22","volume":"121","author":"Gabriel","year":"1998","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.tmaid.2006.03.002_bib71","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/jnnp.51.5.613","article-title":"A prospective study of acute idiopathic neuropathy, II: antecedent events","volume":"51","author":"Winer","year":"1988","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"4","key":"10.1016\/j.tmaid.2006.03.002_bib72","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s100720070081","article-title":"Guillain\u2013Barr\u00e9 syndrome: an Italian multicentre case-control study","volume":"21","year":"2000","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1016\/j.tmaid.2006.03.002_bib73","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1212\/WNL.54.3.620","article-title":"Mild forms of Guillain\u2013Barr\u00e9 syndrome in an epidemiologic survey in The Netherlands","volume":"54","author":"Van Koningsveld","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.tmaid.2006.03.002_bib74","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain\u2013Barr\u00e9 syndrome","volume":"56","author":"Hadden","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.tmaid.2006.03.002_bib75","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain\u2013Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.tmaid.2006.03.002_bib76","first-page":"36","article-title":"The Guillain\u2013Barr\u00e9 syndrome following dengue fever","volume":"48","author":"Esack","year":"1999","journal-title":"West Indian Med J"},{"issue":"6","key":"10.1016\/j.tmaid.2006.03.002_bib77","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/oxfordjournals.aje.a113809","article-title":"An epidemiologic and clinical evaluation of Guillain\u2013Barr\u00e9 syndrome reported in association with the administration of swine influenza vaccines","volume":"119","author":"Langmuir","year":"1984","journal-title":"Am J Epidemiol"},{"issue":"26","key":"10.1016\/j.tmaid.2006.03.002_bib78","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198106253042601","article-title":"Guillain\u2013Barr\u00e9 syndrome and the 1978\u20131979 influenza vaccine","volume":"304","author":"Hurwitz","year":"1981","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.tmaid.2006.03.002_bib79","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1982.03330060038030","article-title":"Guillain\u2013Barr\u00e9 syndrome in the United States, 1979\u20131980 and 1980\u20131981: lack of an association with influenza vaccination","volume":"248","author":"Kaplan","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2006.03.002_bib80","first-page":"506","article-title":"Investigation of a possible association between influenza vaccination and Guillain\u2013Barr\u00e9 Syndrome in the United States, 1990\u201391","volume":"6","author":"Chen","year":"1992","journal-title":"Post Marketing Surveillance"},{"issue":"25","key":"10.1016\/j.tmaid.2006.03.002_bib81","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","article-title":"The Guillain\u2013Barr\u00e9 syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"10.1016\/j.tmaid.2006.03.002_bib82","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0022-510X(78)90232-0","article-title":"Relapsing neuropathy due to tetanus toxoid. Report of a case","volume":"37","author":"Pollard","year":"1978","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.tmaid.2006.03.002_bib83","unstructured":"Galazka AM. The immunological basis for immunisation series: Module 3\u2014Tetanus. WHO\/EPI\/GEN\/98.13.1993. Geneva: World Health Organization;1993."},{"issue":"6","key":"10.1016\/j.tmaid.2006.03.002_bib84","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/01.inf.0000130941.72712.33","article-title":"Possible association of Guillain\u2013Barre syndrome and hepatitis A vaccination","volume":"23","author":"Blumenthal","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.tmaid.2006.03.002_bib85","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/oxfordjournals.aje.a114808","article-title":"Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years","volume":"127","author":"Shaw","year":"1988","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.tmaid.2006.03.002_bib86","first-page":"87","article-title":"Guillain-Barre syndrome occurring after rabies vaccination","volume":"55","author":"Siddiqui","year":"2005","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.tmaid.2006.03.002_bib87","series-title":"Vaccines, 3rd ed","first-page":"743","article-title":"Rabies vaccine","author":"Plotkin","year":"1999"},{"issue":"2","key":"10.1016\/j.tmaid.2006.03.002_bib88","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3476(94)70307-8","article-title":"Epidemiology of Guillain-Barre syndrome in children: relationship of oral polio vaccine administration to occurrence","volume":"124","author":"Rantala","year":"1994","journal-title":"J Pediatr"},{"issue":"1","key":"10.1016\/j.tmaid.2006.03.002_bib89","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/oxfordjournals.aje.a009369","article-title":"Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barre Syndrome","volume":"147","author":"Kinnunen","year":"1998","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.tmaid.2006.03.002_bib90","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1099\/00222615-47-7-563","article-title":"Recent developments in bacterial conjugate vaccines","volume":"47","author":"Goldblatt","year":"1998","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.tmaid.2006.03.002_bib91","unstructured":"Bilukha OO, Rosenstein N, National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC). Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005;54(RR-7):1\u201321."},{"key":"10.1016\/j.tmaid.2006.03.002_bib92","doi-asserted-by":"crossref","unstructured":"Centers for Disease Control and Prevention (CDC). Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine-United States, June-July 2005. MMWR 2005;54(40):1023\u20135.","DOI":"10.1345\/aph.1N122"},{"key":"10.1016\/j.tmaid.2006.03.002_bib93","unstructured":"Food and Drug Administration. Meningococcal polysaccharide (Serogroups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (Menactra) [package insert]. Available at: http:\/\/www.fda.gov\/cber\/products\/mpdtave011405.htm"},{"issue":"3","key":"10.1016\/j.tmaid.2006.03.002_bib94","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/WNL.55.3.452","article-title":"Influenza vaccine and the risk of relapse of Guillain\u2013Barre syndrome","volume":"55","author":"Wijdicks","year":"2000","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.tmaid.2006.03.002_bib95","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jnnp.73.3.348","article-title":"Risk of relapse of Guillain\u2013Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation","volume":"73","author":"Pritchard","year":"2002","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"8","key":"10.1016\/j.tmaid.2006.03.002_bib96","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archneur.62.8.1194","article-title":"Supportive care for patients with Guillain\u2013Barr\u00e9 syndrome","volume":"62","author":"Hughes","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.tmaid.2006.03.002_bib97","unstructured":"Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB, Advisory Committee on Immunization Practices (ACIP), et al., Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005;54 (RR-8):1\u201340."},{"issue":"4","key":"10.1016\/j.tmaid.2006.03.002_bib98","first-page":"283","article-title":"Tetanus immunisation policy in England and Wales-an overview of the literature","volume":"7","author":"Bracebridge","year":"2004","journal-title":"Commun Dis Public Health"},{"issue":"Suppl 1","key":"10.1016\/j.tmaid.2006.03.002_bib99","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1086\/315533","article-title":"The changing epidemiology of diphtheria in the vaccine era","volume":"181","author":"Galazka","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2006.03.002_bib100","first-page":"289","article-title":"Diphtheria in visitors to Africa","volume":"8","year":"1998","journal-title":"Commun Dis Rep CDR Wkly"},{"key":"10.1016\/j.tmaid.2006.03.002_bib101","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/jnnp.74.suppl_2.ii32","article-title":"The neuromuscular junction disorders","volume":"74","author":"Hill","year":"2003","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.tmaid.2006.03.002_bib102","series-title":"Harrison's principles of internal medicine, 15th ed","first-page":"2515","article-title":"Myasthenia gravis and other diseases of the neuromuscular junction","author":"Drachman","year":"2001"},{"issue":"3","key":"10.1016\/j.tmaid.2006.03.002_bib103","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1124\/mol.105.014431","article-title":"Effects of quinine, quinidine, and chloroquine on (alpha) 9 (alpha) 10 nicotinic cholinergic receptors","volume":"68","author":"Ballestero","year":"2005","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.tmaid.2006.03.002_bib104","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0006-8993(95)01349-0","article-title":"Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission","volume":"712","author":"Sieb","year":"1996","journal-title":"Brain Research"},{"key":"10.1016\/j.tmaid.2006.03.002_bib105","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archneur.1989.00520400124033","article-title":"Myasthenic syndrome caused by a direct effect of chloroquine on neuromuscular transmission","volume":"46","author":"Robberecht","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.tmaid.2006.03.002_bib106","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/17843286.1991.11718197","article-title":"Persistent chloroquine-induced myasthenia","volume":"46","author":"De Bleecker","year":"1991","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.tmaid.2006.03.002_bib107","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mus.880110205","article-title":"Chloroquine myopathy and myasthenia-like syndrome","volume":"11","author":"Sghirlanzoni","year":"1988","journal-title":"Muscle & Nerve"},{"issue":"10","key":"10.1016\/j.tmaid.2006.03.002_bib108","first-page":"746","article-title":"Chloroquine neuromyopathies: 4 cases during antimalarial prevention","volume":"142","author":"Leger","year":"1986","journal-title":"Rev Neurol"},{"issue":"1","key":"10.1016\/j.tmaid.2006.03.002_bib109","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM199407073310120","article-title":"Central anticholinergic syndrome with the antimalarial drug mefloquine","volume":"331","author":"Speich","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2006.03.002_bib110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2310\/7060.2002.24216","article-title":"Myasthenia and malaria medicines","volume":"9","author":"Fisher","year":"2002","journal-title":"J Travel Med"},{"issue":"1","key":"10.1016\/j.tmaid.2006.03.002_bib111","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0248-8663(86)80085-6","article-title":"Syndrome myasthenique et doxycycline","volume":"7","author":"Durand","year":"1986","journal-title":"Rev Med Intern"},{"issue":"9276","key":"10.1016\/j.tmaid.2006.03.002_bib112","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2006.03.002_bib113","unstructured":"Centers for Disease Control and Prevention (CDC). Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination 1996\u20132001. MMWR 2001;50 (30):643\u20135."},{"issue":"RR-17","key":"10.1016\/j.tmaid.2006.03.002_bib114","first-page":"1","article-title":"Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002","volume":"51","author":"Cetron","year":"2002","journal-title":"MMWR"},{"key":"10.1016\/j.tmaid.2006.03.002_bib115","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.vaccine.2004.01.026","article-title":"Viscerotropic and neurotropic disease following vaccination with the yellow fever 17D vaccine","volume":"22","author":"Kitchener","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2006.03.002_bib116","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(04)17017-7","article-title":"History of thymoma and yellow fever vaccination","volume":"364","author":"Eidex","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2006.03.002_bib117","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.0105-2896.2005.00275.x","article-title":"Insights into thymic aging and regeneration","volume":"205","author":"Taub","year":"2005","journal-title":"Immunol Rev"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893906000536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893906000536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:56:46Z","timestamp":1761487006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893906000536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S1477893906000536"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2006.03.002","relation":{},"ISSN":["1477-8939"],"issn-type":[{"type":"print","value":"1477-8939"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Travel medicine interventions and neurological disease","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2006.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}